Have a personal or library account? Click to login
Clinical significance of an anti-Dib assessed by flow cytometry Cover

Clinical significance of an anti-Dib assessed by flow cytometry

Immunohematology
Volume 13 (1997): Issue 3 (September 1997)
By: R. Leger,  P. Arndt,  A. CO,  L. O’brien and  G. Garratty  
Paid access
|Nov 2020

Authors

R. Leger

Research Associate, American Red Cross Blood Services, Los Angeles, United States

P. Arndt

Senior Research Associate, American Red Cross Blood Services, Southern California Region, Los Angeles, United States

A. CO

Reference Specialist, American Red Cross Blood Services, Southern California Region, Los Angeles, United States

L. O’brien

Associate Pathologist, Santa Monica-UCLA Medical Center, Santa Monica, United States

G. Garratty

Scientific Director, American Red Cross Blood Services, Southern California Region, Los Angeles, United States
DOI: https://doi.org/10.21307/immunohematology-2019-715 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 93 - 96
Published on: Nov 9, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
anti-Dib,
red cell survival,
flow cytometry,
transfusion reaction
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2020 R. Leger, P. Arndt, A. CO, L. O’brien, G. Garratty, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 13 (1997): Issue 3 (September 1997)Next article